PA-PMI
Project Management Institute (PMI), the world's leading association for project professionals and changemakers, today released its annual Pulse of the Profession® report. Although organizations went through major disruption in the past year, and many projects were put on hold, the report found that organizations were able to rise to the challenge. In fact, of those projects that did forge ahead, 73 percent met original goals and business intent compared to 69 percent last year. 62 percent were completed within budget, and 55 percent on time, compared to 59 percent and 53 percent respectively in last year’s report. As a result, wasted investment due to poor project performance declined to 9.4 percent versus 11.4 percent in last year's survey.
Respondents were asked to characterize their organization’s approach to ways of working, and nearly a third (32 percent) said that any and all possible methods were primarily or exclusively used to solve problems. This is a characteristic of a "gymnastic enterprise.” As outlined in the research, gymnastic enterprises are leading organizations who are able to thrive because they focus on outcomes rather than process, with a clear sense of how to balance structure and governance while embracing change. They empower their people to make change happen by enabling them to master different ways of working, to become well-rounded professionals, and to elevate their power skills. Conversely, 30 percent of respondents shared that their organizations primarily or exclusively consider using methods that have proven effective for them in the past. This is a characteristic of a traditional enterprise. The enduring problem that these traditional enterprises face today is that their structures and ways of working remain very rigid in the midst of change.
“Our 2021 Pulse of the Profession research shows how gymnastic enterprises are thriving in The Project Economy by tailoring their ways of working and empowering their people to lead as changemakers,” said Mike DePrisco, Chief Operating Officer of PMI. “By enabling employees to work smarter, elevating power skills, and building business acumen, gymnastic organizations are delivering financial and societal value regardless of the challenges placed before them.”
The report demonstrates how gymnastic enterprises were able to reap success and nimbly shift when compared to traditional enterprises. For example, gymnastic enterprises were more likely to have high levels of organizational agility (48 percent versus 27 percent) combined with frequent use standardized risk management practices (68 percent versus 64 percent). They were able to adapt faster to the pandemic, being far more likely to have undergone business change in 2020. And, they were much more likely to have seen increased productivity (71 percent versus 53 percent) and better project outcomes in 2020—in turn resulting in less wasted investment (9 percent versus 10.5 percent).
Gymnastic enterprises are also using technology to augment human skills and help their people continuously improve, prioritizing the enterprise-wide adoption of complex problem-solving techniques (47 percent versus 35 percent); AI-driven tools (39 percent versus 30 percent); on-demand, microlearning apps (39 percent versus 30 percent); and career assessment tools (37 percent versus 30 percent). With their focus on augmenting human skills, and on creative collaboration, it’s no surprise that gymnastic enterprises put the highest priority on power skills—especially collaborative leadership (54 percent versus 42 percent of traditional enterprises).
By enabling their people to become changemakers, gymnastic enterprises are better able to sense and respond to shocks, drive change, and face the future, knowing that they have the mindset, skills, and tools that it takes to win. These findings attest to just how important it is for organizations to adopt these approaches.
A total of 3,950 project professionals representing a range of industries and regions, including North America, Europe, Asia Pacific, Sub-Saharan Africa, Latin America, South Asia, Middle East/North Africa, and China were surveyed for the report. The survey was also supplemented by in-depth interviews spanning a wide range of industries and regions.
To read more about how gymnastic enterprises are turning ideas into reality, view the full report here .
About Project Management Institute
Project Management Institute (PMI) is the world's leading professional association for a growing global community of millions of project professionals and changemakers worldwide.
As the world’s leading authority on project management, PMI empowers people to make ideas a reality. Through global advocacy, networking, collaboration, research, and education. PMI prepares organizations and individuals at every stage of their career journey to work smarter so they can drive success in a world of change.
Building on a proud legacy dating to 1969, PMI is a “for-purpose” organization working in nearly every country around the world to advance careers, strengthen organizational success, and enable changemakers with new skills and ways of working to maximize their impact. PMI offerings include globally-recognized standards, certifications, online courses, thought leadership, tools, digital publications, and communities.
Visit us at https://www.pmi.org/ , www.projectmanagement.com , https://www.linkedin.com/company/pminstitute , www.facebook.com/PMInstitute , and on Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005712/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Redefining Acromegaly Care: First Patient Randomized in Debiopharm’s Phase III OXTEND-03™ Trial of 3-Month Debio 4126 Treatment4.12.2025 14:00:00 CET | Press release
OXTEND-03™ (NCT06930625) is a Phase III, multi-center, randomized trial assessing the efficacy and safety of Debio 4126, the first and only octreotide formulation designed for quarterly (3-month) dosing Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company committed to establishing tomorrow’s standards of care in oncology and rare diseases, today announced that the first patient has been randomized in the OXTEND-03™ clinical trial. This pivotal Phase III trial is designed to evaluate the efficacy and safety of Debio 4126, a novel long-acting octreotide formulation and the first potential 3-month somatostatin analogue (SSA), in adults with acromegaly who are currently maintained on somatostatin analogs. OXTEND-03™ is a global trial spanning approximately 75 sites across 21 countries, aiming to enroll around 120 patients. The primary goal of the trial is to confirm Debio 4126’s ability to maintain biochemical control of the disease while significantly
Visa Launches Global Art Collection to Elevate Creators and Celebrate the FIFA World Cup 26™4.12.2025 14:00:00 CET | Press release
Visa spotlights global illustrators and creative small businesses, teaming up with Pharrell Williams’ JOOPITER to accelerate creator growth. Visa today unveiled the first five pieces in its first-ever global art collection celebrating the cultural energy of the FIFA World Cup 26™. Featuring more than twenty artists from six continents, the collection reflects Visa’s belief that creativity drives commerce—and that today’s creators are the entrepreneurs shaping communities and culture around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204080105/en/ Darien Birks (Global) Visa debuted the first five pieces in the collection at an exclusive Miami showcase, “The Art of the Draw”, hosted by multidisciplinary creator KidSuper. The showcase featured the works of artists Darien Birks, Nathan Walker, Cesar Canseco, Ivan Roque, and Rafael Mayani that celebrate the culture and traditions of each host country and host cit
Parse Biosciences Launches Evercode Whole Blood Fixation4.12.2025 14:00:00 CET | Press release
New fixation method streamlines blood sample handling for translational research Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of Evercode™ Whole Blood Fixation, a new kit that enables immediate fixation of whole blood directly at the point of collection. The technology eliminates the need for on-site PBMC isolation, specialized equipment, or trained personnel, allowing translational hematology and pharmaceutical research teams to seamlessly collect blood samples in real-world clinical settings for downstream single cell analysis. Traditional single cell RNA profiling workflows done in a translational setting require a compromise between processing fresh samples, which degrade rapidly and demand skilled handling, and using fixation approaches that capture only a partial transcriptome and cannot provide paired TCR sequences. Fresh PBMC isolation also requires complex workflows and specialized reagents. Everc
LTIMindtree Wins Two 2025 AWS Partner Awards at AWS re:Invent4.12.2025 13:45:00 CET | Press release
Recognized as Application Modernization Consulting Partner of the Year and Industry Partner of the Year - Travel and Hospitality winner LTIMindtree [NSE: LTIM, BSE: 540005], a leading global technology consulting and digital solutions provider, announced that it received the AWS 2025 Geography and Global Partner Awards, recognizing leaders around the globe who play key roles in helping clients drive innovation and build solutions on Amazon Web Services (AWS). LTIMindtree has been awarded Application Modernization Consulting Partner of the Year (Global) and Industry Partner of the Year - Travel and Hospitality. At the AWS re:Invent 2025 Partner Awards Gala, partners were recognized for their specialization, innovation, and collaboration, and for evolving business models that enable success on AWS while supporting their customers. LTIMindtree was recognized as: The Industry Partner of the Year - Travel and Hospitality: Recognized as a trusted transformation partner in Travel and Hospital
Stafford Establishes Timberland Continuation Fund at USD 1.2 billion4.12.2025 10:53:00 CET | Press release
This marks Stafford’s second timberland fund at over USD 1 Billion in 2025, backed by strong existing investor support and new capital commitments from global institutional investors Stafford Capital Partners (“Stafford”) today announced it has established a USD 1.2 billion continuation vehicle, the Stafford International Timberland Continuation Fund (The Continuation Fund or The Fund), marking a significant milestone in the firm’s strategic management of its timberland holdings. The Continuation Fund is a "roll-up" of three of Stafford’s existing core timberland funds – Stafford International Timberland funds VI, VII and VIII – into a new perpetual fund that will hold 74 high-quality core timberland assets. The fully-deployed portfolio took Stafford seven years to construct and holds interests in over 6.3m acres of commercial timberland in the USA, New Zealand, Australia and Latin America. This includes a number of assets that are seen as key strategic holdings in these regions where
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
